"It is not in the stars to hold our destiny but in ourselves." - William Shakespeare
Today, we take look at an oncology name that had a volatile May as good news hit around its pipeline. Despite the overall recent rally in the stock, it looks like a decent covered call candidate given multiple "shots on goal", upcoming potential catalyst, and rising analyst price targets. A full analysis follows in the paragraphs below.
Company Overview
MacroGenics (MGNX) is a Rockville, Maryland-based clinical stage biopharmaceutical company focused on the development of antibody-based therapeutics